hyperplasia/tyrosine

BACKGROUND OF THE INVENTION This invention relates to salt forms of the compound N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N'-[3-(1-methyl-1H-pyrazol-4-yl)-- 5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide, an inhibitor of tyrosine kinases, in particular the receptor tyrosine kinase MET,

FIELD OF THE INVENTION The invention relates to methods for detecting an abnormal prostate condition in an animal. Specifically, the invention relates to methods of detecting an abnormal prostate condition in an animal by detecting the amount of Breast Tumor Kinase (BRK) protein present in the

This invention relates generally to the medical and veterinary medical field of atherosclerotic lesion treatment. More particularly, this invention relates to a catheter device and a method for the local delivery into the vessel wall of specific inhibitors of protein kinase C (PKC) and tyrosine

The present invention relates to the compound of formula (I), ##STR00002## which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing this compound, particularly pharmaceutical

The present invention relates to the compound of formula (I), ##STR00002## which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing this compound, particularly pharmaceutical

The present invention relates to the compound of formula (I), ##STR00002## which has valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, processes for stereoselectively preparing this compound, particularly pharmaceutical

FIELD OF THE INVENTION The present invention relates to bicyclic heterocycles of the general formula ##STR00002## their tautomers, their stereoisomers, their mixtures and their salts, in particular their physiologically tolerable salts with inorganic or organic acids, which have valuable

This application is the national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2007/061842, filed Nov. 3, 2007, which claims priority to European Application No. 06123820.0, filed Nov. 10, 2006, each of which is hereby incorporated by reference in its entirety. The

The present invention relates to spirocyclic heterocycles of general formula ##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological

The present invention relates to spirocyclic heterocycles of general formula ##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological

The present invention relates to cyclohexyloxy-substituted heterocycles of general formula ##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable

The present invention relates to cyclohexyloxy-substituted heterocycles of general formula ##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable

This application is the national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2008/051141, filed Jan. 30, 2008, which claims priority to European Application No. 07101785.9, filed Feb. 6, 2007, and European Application No. 07118700.9, filed Oct. 17, 2007, each of

The present invention relates to bicyclic heterocycles of general formula ##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids which have valuable pharmacological

The present invention relates to bicyclic heterocycles of general formula ##STR00002## the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological